Already Susceptible to Bladder Cancer, Actos Increases Risk in Diabetes Patients
The new study found that people who suffer from diabetes already have a 40 percent higher risk for bladder cancer. Taking Actos (pioglitazone) adds a 22 percent increased risk to an already-high occurrence for bladder cancer, explains Jeffrey A …
Full News here – Read more on DrugWatch.com











